Assess the effectiveness and safety of progesterone receptor modulators in managing endometriosis.

This paper evaluates the clinical effectiveness and safety profiles of various progesterone receptor modulators, including dienogest, gestrinone, and mifepristone, for the management of endometriosis. The authors highlight that while these agents provide effective symptom relief, they possess distinct safety characteristics that necessitate careful consideration during clinical application. The study emphasizes the importance of selecting specific modulators based on individual patient needs to balance therapeutic benefits with potential adverse effects. This paper is centrally about endometriosis — specifically the pharmacological management using progesterone receptor modulators.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works